Blood‐based biomarkers are promising tools to complement clinical variables and imaging
findings in the diagnosis, monitoring and outcome prediction of traumatic brain injury (TBI) …

Background Traumatic brain injury (TBI) is a leading cause of death and long-term disability
worldwide. In addition to primary brain damage, systemic immune alterations occur, with …

Traumatic brain injury (TBI) is currently one of the leading causes of mortality and disability
worldwide. At present, no reliable inflammatory or specific molecular neurobiomarker exists …

Blood biomarkers have been studied to improve the clinical assessment and prognostication
of patients with moderate-severe traumatic brain injury (mo/sTBI). To assess their clinical …

Plasma neurofilament light chain (NF-L) levels were assessed as a diagnostic biomarker for
traumatic brain injury (TBI) and as a prognostic biomarker for somatomotor recovery …

The measurement of blood glial fibrillary acidic protein (GFAP) and ubiquitin carboxy-
terminal hydrolase L1 (UCH-L1) may assist in the management of mild traumatic brain injury …

Background Interleukin 10 (IL-10) and heart fatty acid-binding protein (H-FABP) have gained
interest as diagnostic biomarkers of traumatic brain injury (TBI), but factors affecting their …

The aim of the study was to investigate the correlation of serum changes and markers of
brain injury (BI) in cerebrospinal fluid (CSF) with postoperative cognitive dysfunction (POCD) …

Blood-based biomarkers were recently proposed as predictors of traumatic brain injury (TBI)
outcomes. This would be a critical step forward since the majority of TBI events are mild and …

Abstract Introduction: The TBICheck TM Rapid test is an immunochromatographic rapid test
capable of assisting in the triage of patients with mild Traumatic Brain Injury suspected of …